Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
Parisi I, Tsochatzis E, Wijewantha H, Rodríguez-Perálvarez M, De Luca L, Manousou P, Fatourou E, Pieri G, Papastergiou V, Davies N, Yu D, Luong T, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK.
Parisi I, et al.
Liver Transpl. 2014 Nov;20(11):1327-35. doi: 10.1002/lt.23969.
Liver Transpl. 2014.
PMID: 25088400
Free article.
Clinical Trial.